BEAM:BMV
Beam Therapeutics Inc
453,00Â MX$
arrow_upward
+1,67%(+7,43) 1D
8 tet, 7:30:20 p.d., GMT-6 · MXN
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për BEAM...
Kapitalizimi i tregut
2,65Â mld
Vëllimi mesatar
13,00
Vëllimi
0,00
Maksimumi 52-javor
663,44Â MX$
Minimumi 52-javor
384,79Â MX$
Numri i punonjësve
540
Kapitalizimi i tregut
2,65Â mld
Vëllimi mesatar
13,00
Vëllimi
0,00
Maksimumi 52-javor
663,44Â MX$
Minimumi 52-javor
384,79Â MX$
Numri i punonjësve
540
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Benzinga
·
44 minuta më parë
Mobilicom (NASDAQ: MOB) Launches SwarmiX Secure Mesh Communications Solutions for Drone and Robotic Fleet
Bloomberg.com
·
29 minuta më parë
Watch AI Markups Distorting 'True Earnings Power of S&P,' Says Larry McDonald
The Malaysian Reserve
·
18 minuta më parë
SSA Commissioner Headlines Columbus Day at the NYSE: NYSE Content Update
Yahoo Finance
·
2 orë më parë
A handful of tech stocks are masking an ugly S&P 500 problem
Profili
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks. Wikipedia
Rreth Beam Therapeutics Inc